Pharma Journalist -

Recursion a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development and beyond through disruptive innovation,…
Read More...

Gritstone bio, Inc., a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, and CEPI, the Coalition for Epidemic Preparedness…
Read More...

The European Medicines Agency (EMA) has accepted for review under an accelerated assessment procedure the Marketing Authorization Application (MAA) for olipudase alfa, Sanofi’s…
Read More...

Merck, known as MSD outside the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, for the adjuvant…
Read More...

Merck, known as MSD outside the United States and Canada, announced a pause in enrollment for the IMPOWER 22 (MK-8591-022) and IMPOWER 24 (MK-8591-024) Phase 3 clinical studies…
Read More...

Quantum Genomics, a biopharmaceutical company specializing in the development of first-in-class drugs directly targeting the brain to treat complex/resistant hypertension, has announced…
Read More...

After nearly two years of virtual meetings the industry looks set to meet face to face and have some really important discussions and you are invited to join them.  SMi’s 9th Annual…
Read More...

Jacobio Pharma (1167.HK) has received the Investigational New Drug (the "IND") approval of the combination therapy of KRAS G12C inhibitor JAB-21822 and Cetuximab injection from the…
Read More...

NJ Biopharmaceuticals LLC an expert provider of chemistry and biopharmaceutical services specializing in bioconjugation, custom synthesis, flow chemistry, and process development has…
Read More...

National Resilience, Inc. (Resilience), a technology focused manufacturing company dedicated to broadening access to complex medicines, announced the acquisition of SwiftScale…
Read More...